Catalyst Wire Dossier Catalyst Wire Dossier

Ombitasvir/Paritaprevir/Ritonavir Plus Ribavirin

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ombitasvir/Paritaprevir/Ritonavir Plus Ribavirin, covering 2020-05-12 to 2020-05-12. Get the full timeline:

Most recent: Clinical Trial Update: Ombitasvir /Paritaprevir/Ritonavir Plus Ribavirin on HCV GT4 [Phase 1, Phase 2]

See pricing